Rhonda Farnum
Net worth: 4 M $ as of 2026-07-30
Net worth: 4 M $ as of 2026-07-30
Ms. Rhonda F.
Farnum is a Chief Business Officer & SVP-Medical Affairs at Theravance Biopharma, Inc. Ms. Farnum was previously employed as a Head-Hematology Business Unit by Onyx Pharmaceuticals, Inc. She received her undergraduate degree from the University of Georgia.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-08-19 | 226,790 ( 0.44% ) | 4 M $ | 2026-07-30 |
| Companies | Position | Start |
|---|---|---|
| THERAVANCE BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | - |
| Companies | Position | End |
|---|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Corporate Officer/Principal | 2015-07-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 3 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
University of Georgia
University of Georgia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Theravance Biopharma, Inc.
Theravance Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of human therapeutics products for respiratory diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions